Managing the side effects of psychotropic medications /

Saved in:
Bibliographic Details
Author / Creator:Goldberg, Joseph F., 1963-
Edition:1st ed.
Imprint:Washington, DC : American Psychiatric Pub., c2012.
Description:xxxv, 496 p. : ill. ; 23 cm.
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/8771661
Hidden Bibliographic Details
Other authors / contributors:Ernst, Carrie L., 1975-
American Psychiatric Publishing.
ISBN:9781585624027 (pbk. : alk. paper)
1585624020 (pbk. : alk. paper)
Notes:Includes bibliographical references and index.
Table of Contents:
  • Foreword
  • Preface
  • Introduction
  • List of Abbreviations
  • List of Drugs
  • Part I. General Considerations
  • 1. The Psychiatrist as Physician
  • Primary Care Psychiatry
  • Differentiating Adverse Drug Effects From Primary Illness Symptoms
  • The Nocebo Phenomenon and Proneness to Adverse Effects
  • Negative Therapeutic Reactions
  • Attribution and Causality
  • Paradoxical Adverse Effects
  • Extrapolating "Evidence-Based Research Findings" to "Real-World" Patients
  • Dose Relationships and Adverse Effects
  • FDA Warnings and Precautions
  • Risk-Benefit Analyses
  • General Approach to Assessing Adverse Drug Effects
  • 2. Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics
  • Pharmacokinetics and Pharmacodynamics
  • Toxic Polypharmacy
  • Gender and Racial Differences in Adverse Effects
  • Alcohol
  • Brand Versus Generic Formulations
  • Enantiomeric Versus Racemic Agents, and Parent Versus Metabolite Compounds
  • Drug Blood Levels
  • Pharmacogenomic Predictors of Adverse Effects
  • 3. Vulnerable Populations
  • Patients' Diverse Proneness to Drug Side Effects
  • Children
  • Medically III Patients
  • Older Adults
  • Patients Prone to Somatization
  • 4. Adverse Psychiatric Effects of Nonpsychotropic Medications
  • Analgesics
  • Anticholinergics
  • Anticonvulsants
  • Antimicrobials
  • Antineoplastics
  • Antiparkinsonian Agents
  • Antiretroviral Agents
  • Cardiovascular Drugs
  • Dermatological Agents
  • Gastrointestinal Agents
  • Immunosuppressants
  • Interferon-¿
  • Oral Contraceptives and Intravaginal Rings
  • Smoking Cessation Aids
  • Steroids
  • 5. Adverse Psychiatric Effects of Psychiatric Medications
  • Activation and Mania/Hypomania or Mixed States
  • Anxiety and Panic
  • Clinical Trial Subjects With Psychiatric Illness
  • Discontinuation Phenomena
  • Disinhibition and Impaired Impulse Control
  • Emotional Dulling
  • Psychosis
  • Suicidal Thinking or Behavior
  • 6. What Nonmedical Therapists Should Know About Adverse Drug Effects
  • Part II. Organ Systems
  • 7. Cardiovascular System
  • Arrhythmias and Palpitations
  • Cerebrovascular Accidents
  • Dyslipidemias
  • Edema
  • Hypertension
  • Myocarditis and Cardiomyopathy
  • Orthostatic Hypotension
  • 8. Dermatological System
  • Alopecia
  • Hyperhidrosis
  • Photosensitivity
  • Pruritus
  • Skin Rashes
  • 9. Ear, Nose, and Throat
  • Bruxis
  • Dysarthria
  • Dysgeusia
  • Oral Lesions
  • Sialorrhea
  • Stomatodynia (Burning Mouth Syndrome)
  • Xerostomia
  • 10. Electrolyte Abnormalities
  • Hyponatremia and SIADH
  • Metabolic Acidosis and Alkalosis
  • 11. Endocrinopathies
  • Bone Demineralization and Osteoporosis
  • Glycemic Dysregulation and Diabetes Mellitus
  • Hyperprolactinemia, Galactorrhea, and Gynecomastia
  • Menstrual Disturbances and Polycystic Ovary Syndrome
  • Parathyroid Abnormalities
  • Thyroid Abnormalities
  • 12. Gastrointestinal System
  • Diarrhea, Hypermotility, and Constipation
  • Gastrointestinal Bleeding
  • Hepatic Impairment and Transaminitis
  • Hyperammonemia
  • Malabsorption Disorders
  • Nausea and Gastrointestinal Upset
  • Pancreatitis
  • 13. Genitourinary and Renal Systems
  • Dysuria and Urinary Retention
  • Enuresis and Urinary Incontinence
  • Nephrotic Syndrome
  • Nephrotoxicity and Nephrogenic Diabetes Insipidus
  • Priapism
  • Renal Calculi
  • Renal Insufficiency
  • Sexual Dysfunction
  • 14. Hematological System
  • Myelosuppression: Agranulocytosis and Thrombocytopenia
  • Platelet Aggregation Disorders and Bleeding Risk
  • Red Blood Cells
  • 15. Musculoskeletal System
  • Joint Pain
  • Leg Cramps
  • Myalgias
  • 16. Neurological System
  • Akathisia and Extrapyramidal Adverse Effects
  • Cognitive Complaints
  • Delirium and Encephalopathy
  • Dyskinesias and Dystonias
  • Fatigue and Sedation
  • Headache
  • Motor Tics
  • Muscle Twitching, Fasciculations, and Myoclonus
  • Nystagmus
  • Oculogyric Crises
  • Paresthesias and Neuropathies
  • Seizures
  • Tinnitus
  • Tremor
  • Yawning
  • 11. Ophthalmological System
  • Cataracts
  • Diplopia/Blurred Vision
  • Glaucoma
  • Retinopathies
  • 18. Sleep Disturbances
  • Hypersomnia and Sleep Attacks
  • Insomnia
  • Nightmares and Vivid Dreams
  • Parasomnias
  • 19. Systemic Reactions
  • Allergic Reactions and Angioedema
  • Antiepileptic Hypersensitivity Reactions
  • Body Temperature Dysregulation
  • Discontinuation Syndromes
  • Drug-Induced Lupus Erythematosus
  • Neuroleptic Malignant Syndrome
  • Serotonin Syndrome
  • Weight Gain
  • Weight Loss
  • 20. Pregnancy and the Puerperium
  • Breast-Feeding and Adverse Events
  • Growth Effects
  • Teratogenicity
  • Withdrawal in the Newborn
  • 21. Emergency Situations
  • Part III. Summary Recommendations
  • 22. Summary Recommendations
  • The Future
  • Appendix 1. Self-Assessment Questions and Answers
  • Appendix 2. Resources for Practitioners
  • References.
  • Index.